Inventor · disambiguated record
Nicholas Barczak
Also filed as: Barczak Nicholas
15 granted patents·3 pending applications·131 citations·filing 2016–2023
92Inventor score
Top patents by PatentIndex Score
18 records- 0198US9630922B23-spiro-7-hydroxamic acid tetralins as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Apr 25, 2017·49 cites·33 claims
- 0297US9637453B23-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted May 2, 2017·51 cites·31 claims
- 0393US9745253B2Alpha-cinnamide compounds and compositions as HDAC8 inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Aug 29, 2017·10 cites·53 claims
- 0489US10538496B2Methods using HDAC11 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·3 cites·5 claims
- 0589US10508088B2Methods using HDAC11 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 17, 2019·3 cites·11 claims
- 0688US10266487B2Alpha-cinnamide compounds and compositions as HDAC8 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Apr 23, 2019·4 cites·16 claims
- 0787US11345672B2Methods using HDAC11 inhibitorsVALO HEALTH INC·Filed 2019·Granted May 31, 2022·2 cites·19 claims
- 0885US10988441B2Alpha-cinnamide compounds and compositions as HDAC8 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Apr 27, 2021·1 cites·20 claims
- 0985US10029995B2[6,6] fused bicyclic HDAC8 inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Jul 24, 2018·3 cites·39 claims
- 1084US10508077B2Alpha-cinnamide compounds and compositions as HDAC8 inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Dec 17, 2019·2 cites·20 claims
- 1184US10370343B2[6,6] Fused bicyclic HDAC8 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Aug 6, 2019·2 cites·18 claims
- 1282US10829460B2[6,6] fused bicyclic HDAC8 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Nov 10, 2020·1 cites·20 claims
- 1382US2023406830A1[6,6] fused bicyclic hdac8 inhibitorsVALO HEALTH INC·Filed 2023·Application pending·0 cites
- 1480US12479807B2Methods using HDAC11 inhibitorsVALO HEALTH INC·Filed 2022·Granted Nov 25, 2025·0 cites·2 claims
- 1580US11919839B2Alpha-cinnamide compounds and compositions as HDAC8 inhibitorsVALO HEALTH INC·Filed 2021·Granted Mar 5, 2024·0 cites·20 claims
- 1673US11414392B2[6,6] fused bicyclic HDAC8 inhibitorsVALO HEALTH INC·Filed 2020·Granted Aug 16, 2022·0 cites·20 claims
- 1767US2018127386A1Methods using hdac11 inhibitorsFORMA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1863US2018044282A1Alpha-cinnamide compounds and compositions as hdac8 inhibitorsFORMA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →